nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—SLC22A1—hematologic cancer	0.159	0.775	CbGaD
Quinidine—ABCB1—hematologic cancer	0.0462	0.225	CbGaD
Quinidine—ABCB11—Daunorubicin—hematologic cancer	0.0179	0.0342	CbGbCtD
Quinidine—SLCO1A2—Chlorambucil—hematologic cancer	0.016	0.0306	CbGbCtD
Quinidine—SLC22A2—Daunorubicin—hematologic cancer	0.0115	0.022	CbGbCtD
Quinidine—ORM1—Imatinib—hematologic cancer	0.0107	0.0204	CbGbCtD
Quinidine—SLC22A2—Cytarabine—hematologic cancer	0.0102	0.0194	CbGbCtD
Quinidine—SLC22A2—Cladribine—hematologic cancer	0.0096	0.0183	CbGbCtD
Quinidine—ABCC2—Daunorubicin—hematologic cancer	0.00941	0.018	CbGbCtD
Quinidine—SLC22A1—Cytarabine—hematologic cancer	0.00883	0.0169	CbGbCtD
Quinidine—SLC22A2—Imatinib—hematologic cancer	0.00883	0.0169	CbGbCtD
Quinidine—CYP1A2—Anagrelide—hematologic cancer	0.00864	0.0165	CbGbCtD
Quinidine—CYP1A1—Methoxsalen—hematologic cancer	0.00863	0.0165	CbGbCtD
Quinidine—CYP2B6—Thiotepa—hematologic cancer	0.00846	0.0161	CbGbCtD
Quinidine—SLC22A1—Cladribine—hematologic cancer	0.00834	0.0159	CbGbCtD
Quinidine—CYP1A1—Bortezomib—hematologic cancer	0.00821	0.0157	CbGbCtD
Quinidine—CYP1A1—Daunorubicin—hematologic cancer	0.00785	0.015	CbGbCtD
Quinidine—SLC22A1—Imatinib—hematologic cancer	0.00767	0.0146	CbGbCtD
Quinidine—SLC22A8—Mercaptopurine—hematologic cancer	0.00766	0.0146	CbGbCtD
Quinidine—ABCB11—Vinblastine—hematologic cancer	0.00761	0.0145	CbGbCtD
Quinidine—ABCB11—Vincristine—hematologic cancer	0.00749	0.0143	CbGbCtD
Quinidine—CYP1A1—Thalidomide—hematologic cancer	0.00715	0.0137	CbGbCtD
Quinidine—CYP1A1—Dacarbazine—hematologic cancer	0.00615	0.0117	CbGbCtD
Quinidine—SLCO1A2—Prednisolone—hematologic cancer	0.00607	0.0116	CbGbCtD
Quinidine—SLCO1A2—Prednisone—hematologic cancer	0.00573	0.0109	CbGbCtD
Quinidine—ABCB11—Dexamethasone—hematologic cancer	0.00564	0.0108	CbGbCtD
Quinidine—CYP2E1—Thalidomide—hematologic cancer	0.00553	0.0105	CbGbCtD
Quinidine—CYP2C9—Bexarotene—hematologic cancer	0.00539	0.0103	CbGbCtD
Quinidine—ABCB1—Lenalidomide—hematologic cancer	0.00523	0.00999	CbGbCtD
Quinidine—SLCO1B1—Irinotecan—hematologic cancer	0.00513	0.00978	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00504	0.00962	CbGbCtD
Quinidine—CYP3A7—Ifosfamide—hematologic cancer	0.00504	0.00962	CbGbCtD
Quinidine—SLC22A2—Vinblastine—hematologic cancer	0.0049	0.00936	CbGbCtD
Quinidine—CYP1A1—Dasatinib—hematologic cancer	0.00483	0.00922	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00481	0.00919	CbGbCtD
Quinidine—CYP3A7—Imatinib—hematologic cancer	0.00481	0.00919	CbGbCtD
Quinidine—CYP2B6—Ifosfamide—hematologic cancer	0.0048	0.00916	CbGbCtD
Quinidine—CYP2E1—Dacarbazine—hematologic cancer	0.00475	0.00907	CbGbCtD
Quinidine—CYP2C8—Bortezomib—hematologic cancer	0.00474	0.00904	CbGbCtD
Quinidine—ABCB11—Doxorubicin—hematologic cancer	0.00468	0.00893	CbGbCtD
Quinidine—CYP2D6—Lomustine—hematologic cancer	0.00458	0.00875	CbGbCtD
Quinidine—CYP1A2—Carmustine—hematologic cancer	0.00454	0.00866	CbGbCtD
Quinidine—ABCC2—Irinotecan—hematologic cancer	0.0045	0.00859	CbGbCtD
Quinidine—SLC22A2—Cisplatin—hematologic cancer	0.0045	0.00858	CbGbCtD
Quinidine—CYP2C9—Idarubicin—hematologic cancer	0.00447	0.00853	CbGbCtD
Quinidine—CYP2B6—Nilotinib—hematologic cancer	0.00417	0.00795	CbGbCtD
Quinidine—CYP2D6—Idarubicin—hematologic cancer	0.00409	0.0078	CbGbCtD
Quinidine—ABCC2—Vinblastine—hematologic cancer	0.004	0.00764	CbGbCtD
Quinidine—ABCC2—Vincristine—hematologic cancer	0.00394	0.00751	CbGbCtD
Quinidine—CYP1A2—Methoxsalen—hematologic cancer	0.00386	0.00736	CbGbCtD
Quinidine—CYP2E1—Mitoxantrone—hematologic cancer	0.00369	0.00704	CbGbCtD
Quinidine—ABCC2—Cisplatin—hematologic cancer	0.00367	0.00701	CbGbCtD
Quinidine—CYP1A2—Bortezomib—hematologic cancer	0.00367	0.007	CbGbCtD
Quinidine—CYP2C8—Ifosfamide—hematologic cancer	0.00363	0.00694	CbGbCtD
Quinidine—ABCC2—Etoposide—hematologic cancer	0.00361	0.00688	CbGbCtD
Quinidine—SLCO1A2—Dexamethasone—hematologic cancer	0.00358	0.00683	CbGbCtD
Quinidine—CYP1A2—Daunorubicin—hematologic cancer	0.00351	0.0067	CbGbCtD
Quinidine—CYP2D6—Hydroxyurea—hematologic cancer	0.00347	0.00663	CbGbCtD
Quinidine—CYP1A2—Alitretinoin—hematologic cancer	0.00344	0.00656	CbGbCtD
Quinidine—CYP2C9—Bortezomib—hematologic cancer	0.00331	0.00631	CbGbCtD
Quinidine—CYP1A2—Thalidomide—hematologic cancer	0.0032	0.0061	CbGbCtD
Quinidine—CYP2C8—Nilotinib—hematologic cancer	0.00316	0.00602	CbGbCtD
Quinidine—CYP3A4—Bexarotene—hematologic cancer	0.00314	0.00598	CbGbCtD
Quinidine—ABCB1—Daunorubicin—hematologic cancer	0.00307	0.00586	CbGbCtD
Quinidine—CYP2D6—Bortezomib—hematologic cancer	0.00302	0.00577	CbGbCtD
Quinidine—CYP3A7—Irinotecan—hematologic cancer	0.00301	0.00574	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00301	0.00574	CbGbCtD
Quinidine—ABCB1—Alitretinoin—hematologic cancer	0.00301	0.00574	CbGbCtD
Quinidine—ABCC2—Dexamethasone—hematologic cancer	0.00297	0.00566	CbGbCtD
Quinidine—CYP3A4—Busulfan—hematologic cancer	0.00292	0.00556	CbGbCtD
Quinidine—CYP3A4—Lomustine—hematologic cancer	0.00292	0.00556	CbGbCtD
Quinidine—CYP2C9—Thalidomide—hematologic cancer	0.00288	0.0055	CbGbCtD
Quinidine—SLCO1A2—Methotrexate—hematologic cancer	0.00287	0.00549	CbGbCtD
Quinidine—CYP2B6—Irinotecan—hematologic cancer	0.00286	0.00546	CbGbCtD
Quinidine—CYP1A2—Dacarbazine—hematologic cancer	0.00275	0.00524	CbGbCtD
Quinidine—CYP2C9—Teniposide—hematologic cancer	0.00275	0.00524	CbGbCtD
Quinidine—SLCO1B1—Methotrexate—hematologic cancer	0.00271	0.00518	CbGbCtD
Quinidine—CYP1A2—Imatinib—hematologic cancer	0.00269	0.00513	CbGbCtD
Quinidine—CYP3A7—Vincristine—hematologic cancer	0.00263	0.00502	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00263	0.00502	CbGbCtD
Quinidine—CYP3A4—Thiotepa—hematologic cancer	0.0026	0.00496	CbGbCtD
Quinidine—CYP2C9—Ifosfamide—hematologic cancer	0.00254	0.00484	CbGbCtD
Quinidine—SLC22A8—Methotrexate—hematologic cancer	0.0025	0.00478	CbGbCtD
Quinidine—CYP1A1—Dexamethasone—hematologic cancer	0.00247	0.00472	CbGbCtD
Quinidine—ABCC2—Doxorubicin—hematologic cancer	0.00246	0.00469	CbGbCtD
Quinidine—CYP2C9—Imatinib—hematologic cancer	0.00242	0.00462	CbGbCtD
Quinidine—ABCC2—Methotrexate—hematologic cancer	0.00238	0.00455	CbGbCtD
Quinidine—ABCB1—Imatinib—hematologic cancer	0.00235	0.00449	CbGbCtD
Quinidine—CYP2B6—Cisplatin—hematologic cancer	0.00233	0.00445	CbGbCtD
Quinidine—CYP2E1—Etoposide—hematologic cancer	0.00233	0.00444	CbGbCtD
Quinidine—CYP2D6—Imatinib—hematologic cancer	0.00221	0.00423	CbGbCtD
Quinidine—KCNK6—gonad—hematologic cancer	0.0022	0.0727	CbGeAlD
Quinidine—CYP2C9—Nilotinib—hematologic cancer	0.0022	0.0042	CbGbCtD
Quinidine—CYP1A2—Dasatinib—hematologic cancer	0.00216	0.00412	CbGbCtD
Quinidine—ABCB1—Nilotinib—hematologic cancer	0.00214	0.00408	CbGbCtD
Quinidine—ABCB1—Vinorelbine—hematologic cancer	0.00212	0.00404	CbGbCtD
Quinidine—CYP3A4—Methoxsalen—hematologic cancer	0.00202	0.00386	CbGbCtD
Quinidine—CYP2D6—Nilotinib—hematologic cancer	0.00201	0.00384	CbGbCtD
Quinidine—CYP2D6—Vinorelbine—hematologic cancer	0.002	0.00381	CbGbCtD
Quinidine—CYP3A7—Dexamethasone—hematologic cancer	0.00198	0.00378	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00198	0.00378	CbGbCtD
Quinidine—CYP3A4—Bortezomib—hematologic cancer	0.00192	0.00367	CbGbCtD
Quinidine—CYP2E1—Dexamethasone—hematologic cancer	0.00191	0.00365	CbGbCtD
Quinidine—ABCB1—Dasatinib—hematologic cancer	0.00189	0.0036	CbGbCtD
Quinidine—CYP2B6—Dexamethasone—hematologic cancer	0.00189	0.0036	CbGbCtD
Quinidine—ABCB1—Mitoxantrone—hematologic cancer	0.00186	0.00356	CbGbCtD
Quinidine—CYP3A4—Daunorubicin—hematologic cancer	0.00184	0.00351	CbGbCtD
Quinidine—CYP2C8—Etoposide—hematologic cancer	0.00174	0.00332	CbGbCtD
Quinidine—ABCB1—Betamethasone—hematologic cancer	0.00166	0.00317	CbGbCtD
Quinidine—ABCB1—Gemcitabine—hematologic cancer	0.00165	0.00314	CbGbCtD
Quinidine—ABCB1—Prednisolone—hematologic cancer	0.00164	0.00313	CbGbCtD
Quinidine—CYP3A4—Cytarabine—hematologic cancer	0.00162	0.00309	CbGbCtD
Quinidine—CYP3A4—Teniposide—hematologic cancer	0.0016	0.00305	CbGbCtD
Quinidine—KCNK6—testis—hematologic cancer	0.00159	0.0524	CbGeAlD
Quinidine—CYP2B6—Doxorubicin—hematologic cancer	0.00156	0.00299	CbGbCtD
Quinidine—ABCB1—Prednisone—hematologic cancer	0.00155	0.00296	CbGbCtD
Quinidine—CYP3A4—Ifosfamide—hematologic cancer	0.00147	0.00281	CbGbCtD
Quinidine—ABCB1—Irinotecan—hematologic cancer	0.00147	0.0028	CbGbCtD
Quinidine—CYP2C8—Dexamethasone—hematologic cancer	0.00143	0.00273	CbGbCtD
Quinidine—CYP3A4—Imatinib—hematologic cancer	0.00141	0.00269	CbGbCtD
Quinidine—CYP1A2—Etoposide—hematologic cancer	0.00134	0.00257	CbGbCtD
Quinidine—CYP3A4—Ruxolitinib—hematologic cancer	0.00133	0.00253	CbGbCtD
Quinidine—ABCB1—Vinblastine—hematologic cancer	0.00131	0.00249	CbGbCtD
Quinidine—ABCB1—Vincristine—hematologic cancer	0.00128	0.00245	CbGbCtD
Quinidine—CYP3A4—Nilotinib—hematologic cancer	0.00128	0.00244	CbGbCtD
Quinidine—CYP3A4—Vinorelbine—hematologic cancer	0.00127	0.00242	CbGbCtD
Quinidine—CYP2C9—Cisplatin—hematologic cancer	0.00123	0.00235	CbGbCtD
Quinidine—CYP2D6—Vinblastine—hematologic cancer	0.00123	0.00235	CbGbCtD
Quinidine—ABCB1—Cisplatin—hematologic cancer	0.0012	0.00228	CbGbCtD
Quinidine—ABCB1—Etoposide—hematologic cancer	0.00118	0.00224	CbGbCtD
Quinidine—CYP3A4—Triamcinolone—hematologic cancer	0.00116	0.00221	CbGbCtD
Quinidine—CYP3A4—Dasatinib—hematologic cancer	0.00113	0.00216	CbGbCtD
Quinidine—CYP3A4—Mitoxantrone—hematologic cancer	0.00112	0.00213	CbGbCtD
Quinidine—CYP2C9—Dexamethasone—hematologic cancer	0.000996	0.0019	CbGbCtD
Quinidine—CYP3A4—Betamethasone—hematologic cancer	0.000996	0.0019	CbGbCtD
Quinidine—CYP3A4—Prednisolone—hematologic cancer	0.000982	0.00187	CbGbCtD
Quinidine—ABCB1—Dexamethasone—hematologic cancer	0.000967	0.00184	CbGbCtD
Quinidine—CYP3A4—Prednisone—hematologic cancer	0.000928	0.00177	CbGbCtD
Quinidine—CYP2D6—Dexamethasone—hematologic cancer	0.000911	0.00174	CbGbCtD
Quinidine—CYP3A4—Irinotecan—hematologic cancer	0.00088	0.00168	CbGbCtD
Quinidine—SCN2A—hematopoietic system—hematologic cancer	0.000875	0.0289	CbGeAlD
Quinidine—ABCB1—Doxorubicin—hematologic cancer	0.000802	0.00153	CbGbCtD
Quinidine—Quinine—SLC22A1—hematologic cancer	0.000795	0.775	CrCbGaD
Quinidine—CYP3A4—Vinblastine—hematologic cancer	0.000782	0.00149	CbGbCtD
Quinidine—ABCB1—Methotrexate—hematologic cancer	0.000777	0.00148	CbGbCtD
Quinidine—CYP3A4—Vincristine—hematologic cancer	0.000769	0.00147	CbGbCtD
Quinidine—SLCO1B1—hematopoietic system—hematologic cancer	0.000759	0.025	CbGeAlD
Quinidine—CYP2D6—Doxorubicin—hematologic cancer	0.000756	0.00144	CbGbCtD
Quinidine—KCNK1—lung—hematologic cancer	0.000746	0.0246	CbGeAlD
Quinidine—CYP3A4—Etoposide—hematologic cancer	0.000705	0.00134	CbGbCtD
Quinidine—KCNK1—testis—hematologic cancer	0.000704	0.0232	CbGeAlD
Quinidine—ORM1—hematopoietic system—hematologic cancer	0.0007	0.0231	CbGeAlD
Quinidine—ABCB11—testis—hematologic cancer	0.00062	0.0204	CbGeAlD
Quinidine—SLCO1A2—hematopoietic system—hematologic cancer	0.000617	0.0204	CbGeAlD
Quinidine—SLC22A8—hematopoietic system—hematologic cancer	0.00059	0.0194	CbGeAlD
Quinidine—SCN2A—blood—hematologic cancer	0.00058	0.0191	CbGeAlD
Quinidine—CYP3A4—Dexamethasone—hematologic cancer	0.000579	0.00111	CbGbCtD
Quinidine—SCN1A—lung—hematologic cancer	0.000554	0.0183	CbGeAlD
Quinidine—KCNK1—lymph node—hematologic cancer	0.00051	0.0168	CbGeAlD
Quinidine—SCN3A—blood—hematologic cancer	0.00051	0.0168	CbGeAlD
Quinidine—SCN5A—blood—hematologic cancer	0.000508	0.0168	CbGeAlD
Quinidine—SLCO1B1—blood—hematologic cancer	0.000503	0.0166	CbGeAlD
Quinidine—SCN3A—bone marrow—hematologic cancer	0.000493	0.0163	CbGeAlD
Quinidine—CYP3A4—Doxorubicin—hematologic cancer	0.000481	0.000917	CbGbCtD
Quinidine—KCNH2—hematopoietic system—hematologic cancer	0.000472	0.0156	CbGeAlD
Quinidine—ORM1—blood—hematologic cancer	0.000464	0.0153	CbGeAlD
Quinidine—ORM1—bone marrow—hematologic cancer	0.000449	0.0148	CbGeAlD
Quinidine—SCN3A—lung—hematologic cancer	0.000447	0.0147	CbGeAlD
Quinidine—SLC22A4—blood—hematologic cancer	0.000446	0.0147	CbGeAlD
Quinidine—SLC22A4—bone marrow—hematologic cancer	0.000432	0.0142	CbGeAlD
Quinidine—CYP2C8—hematopoietic system—hematologic cancer	0.000431	0.0142	CbGeAlD
Quinidine—SLC22A1—blood—hematologic cancer	0.000425	0.014	CbGeAlD
Quinidine—SCN3A—testis—hematologic cancer	0.000421	0.0139	CbGeAlD
Quinidine—ORM1—lung—hematologic cancer	0.000407	0.0134	CbGeAlD
Quinidine—CYP1A2—hematopoietic system—hematologic cancer	0.000404	0.0133	CbGeAlD
Quinidine—CYP1A1—hematopoietic system—hematologic cancer	0.000398	0.0131	CbGeAlD
Quinidine—SLC22A4—lung—hematologic cancer	0.000391	0.0129	CbGeAlD
Quinidine—SLC22A8—blood—hematologic cancer	0.000391	0.0129	CbGeAlD
Quinidine—CYP2B6—hematopoietic system—hematologic cancer	0.000387	0.0128	CbGeAlD
Quinidine—CYP2C9—hematopoietic system—hematologic cancer	0.000383	0.0126	CbGeAlD
Quinidine—ABCC2—blood—hematologic cancer	0.000381	0.0126	CbGeAlD
Quinidine—CYP2E1—hematopoietic system—hematologic cancer	0.000363	0.012	CbGeAlD
Quinidine—SLCO1A2—lung—hematologic cancer	0.000359	0.0118	CbGeAlD
Quinidine—SLCO1A2—testis—hematologic cancer	0.000338	0.0112	CbGeAlD
Quinidine—ABCC2—testis—hematologic cancer	0.000315	0.0104	CbGeAlD
Quinidine—KCNH2—blood—hematologic cancer	0.000312	0.0103	CbGeAlD
Quinidine—SCN3A—lymph node—hematologic cancer	0.000306	0.0101	CbGeAlD
Quinidine—KCNH2—bone marrow—hematologic cancer	0.000302	0.00997	CbGeAlD
Quinidine—SLC22A5—blood—hematologic cancer	0.000295	0.00974	CbGeAlD
Quinidine—CYP2B6—gonad—hematologic cancer	0.000294	0.00971	CbGeAlD
Quinidine—CYP3A4—hematopoietic system—hematologic cancer	0.000292	0.00964	CbGeAlD
Quinidine—CYP2D6—hematopoietic system—hematologic cancer	0.000288	0.00949	CbGeAlD
Quinidine—CYP2C8—blood—hematologic cancer	0.000286	0.00943	CbGeAlD
Quinidine—ORM1—lymph node—hematologic cancer	0.000278	0.00917	CbGeAlD
Quinidine—SLC22A4—lymph node—hematologic cancer	0.000268	0.00882	CbGeAlD
Quinidine—CYP1A2—blood—hematologic cancer	0.000267	0.00882	CbGeAlD
Quinidine—CYP1A1—blood—hematologic cancer	0.000264	0.0087	CbGeAlD
Quinidine—SLC22A5—lung—hematologic cancer	0.000259	0.00854	CbGeAlD
Quinidine—KCNH2—testis—hematologic cancer	0.000258	0.00852	CbGeAlD
Quinidine—CYP2B6—blood—hematologic cancer	0.000256	0.00846	CbGeAlD
Quinidine—CYP2C9—blood—hematologic cancer	0.000254	0.00838	CbGeAlD
Quinidine—SLC22A5—testis—hematologic cancer	0.000244	0.00806	CbGeAlD
Quinidine—CYP2E1—blood—hematologic cancer	0.000241	0.00794	CbGeAlD
Quinidine—CYP2C8—testis—hematologic cancer	0.000236	0.0078	CbGeAlD
Quinidine—CYP1A2—lung—hematologic cancer	0.000234	0.00773	CbGeAlD
Quinidine—CYP1A1—lung—hematologic cancer	0.000231	0.00763	CbGeAlD
Quinidine—Quinine—ABCB1—hematologic cancer	0.000231	0.225	CrCbGaD
Quinidine—ABCC2—lymph node—hematologic cancer	0.000228	0.00754	CbGeAlD
Quinidine—CYP2B6—lung—hematologic cancer	0.000225	0.00741	CbGeAlD
Quinidine—CYP2B6—testis—hematologic cancer	0.000212	0.007	CbGeAlD
Quinidine—CYP2E1—lung—hematologic cancer	0.000211	0.00696	CbGeAlD
Quinidine—ABCB1—hematopoietic system—hematologic cancer	0.000207	0.00682	CbGeAlD
Quinidine—CYP2E1—testis—hematologic cancer	0.000199	0.00657	CbGeAlD
Quinidine—CYP3A4—blood—hematologic cancer	0.000194	0.00639	CbGeAlD
Quinidine—CYP2D6—blood—hematologic cancer	0.000191	0.00628	CbGeAlD
Quinidine—KCNH2—lymph node—hematologic cancer	0.000187	0.00618	CbGeAlD
Quinidine—SLC22A5—lymph node—hematologic cancer	0.000177	0.00584	CbGeAlD
Quinidine—CYP1A1—lymph node—hematologic cancer	0.000158	0.00522	CbGeAlD
Quinidine—CYP2D6—testis—hematologic cancer	0.000158	0.0052	CbGeAlD
Quinidine—ABCB1—gonad—hematologic cancer	0.000157	0.00519	CbGeAlD
Quinidine—ABCB1—blood—hematologic cancer	0.000137	0.00452	CbGeAlD
Quinidine—ABCB1—bone marrow—hematologic cancer	0.000133	0.00437	CbGeAlD
Quinidine—ABCB1—lung—hematologic cancer	0.00012	0.00396	CbGeAlD
Quinidine—ABCB1—testis—hematologic cancer	0.000113	0.00374	CbGeAlD
Quinidine—ABCB1—lymph node—hematologic cancer	8.22e-05	0.00271	CbGeAlD
Quinidine—Chills—Methotrexate—hematologic cancer	2.01e-05	0.000118	CcSEcCtD
Quinidine—Headache—Irinotecan—hematologic cancer	2e-05	0.000117	CcSEcCtD
Quinidine—Headache—Mitoxantrone—hematologic cancer	2e-05	0.000117	CcSEcCtD
Quinidine—Nausea—Ifosfamide—hematologic cancer	2e-05	0.000117	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.99e-05	0.000116	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.99e-05	0.000116	CcSEcCtD
Quinidine—Myalgia—Prednisone—hematologic cancer	1.99e-05	0.000116	CcSEcCtD
Quinidine—Feeling abnormal—Triamcinolone—hematologic cancer	1.99e-05	0.000116	CcSEcCtD
Quinidine—Diarrhoea—Cisplatin—hematologic cancer	1.99e-05	0.000116	CcSEcCtD
Quinidine—Erythema multiforme—Epirubicin—hematologic cancer	1.98e-05	0.000116	CcSEcCtD
Quinidine—Vomiting—Gemcitabine—hematologic cancer	1.98e-05	0.000116	CcSEcCtD
Quinidine—Bradycardia—Doxorubicin—hematologic cancer	1.98e-05	0.000115	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.97e-05	0.000115	CcSEcCtD
Quinidine—Mental disorder—Methotrexate—hematologic cancer	1.96e-05	0.000115	CcSEcCtD
Quinidine—Rash—Gemcitabine—hematologic cancer	1.96e-05	0.000115	CcSEcCtD
Quinidine—Dermatitis—Gemcitabine—hematologic cancer	1.96e-05	0.000115	CcSEcCtD
Quinidine—Eye disorder—Epirubicin—hematologic cancer	1.96e-05	0.000115	CcSEcCtD
Quinidine—Hypersensitivity—Etoposide—hematologic cancer	1.96e-05	0.000114	CcSEcCtD
Quinidine—Tinnitus—Epirubicin—hematologic cancer	1.96e-05	0.000114	CcSEcCtD
Quinidine—Erythema—Methotrexate—hematologic cancer	1.95e-05	0.000114	CcSEcCtD
Quinidine—Malnutrition—Methotrexate—hematologic cancer	1.95e-05	0.000114	CcSEcCtD
Quinidine—Haemoglobin—Doxorubicin—hematologic cancer	1.95e-05	0.000114	CcSEcCtD
Quinidine—Headache—Gemcitabine—hematologic cancer	1.95e-05	0.000114	CcSEcCtD
Quinidine—Nausea—Vincristine—hematologic cancer	1.95e-05	0.000114	CcSEcCtD
Quinidine—Cardiac disorder—Epirubicin—hematologic cancer	1.95e-05	0.000114	CcSEcCtD
Quinidine—Flushing—Epirubicin—hematologic cancer	1.95e-05	0.000114	CcSEcCtD
Quinidine—Haemorrhage—Doxorubicin—hematologic cancer	1.94e-05	0.000113	CcSEcCtD
Quinidine—Hepatitis—Doxorubicin—hematologic cancer	1.94e-05	0.000113	CcSEcCtD
Quinidine—Hypersensitivity—Prednisolone—hematologic cancer	1.93e-05	0.000113	CcSEcCtD
Quinidine—Urinary tract disorder—Doxorubicin—hematologic cancer	1.92e-05	0.000112	CcSEcCtD
Quinidine—Urticaria—Triamcinolone—hematologic cancer	1.92e-05	0.000112	CcSEcCtD
Quinidine—Asthenia—Etoposide—hematologic cancer	1.91e-05	0.000111	CcSEcCtD
Quinidine—Body temperature increased—Triamcinolone—hematologic cancer	1.91e-05	0.000111	CcSEcCtD
Quinidine—Oedema—Prednisone—hematologic cancer	1.91e-05	0.000111	CcSEcCtD
Quinidine—Urethral disorder—Doxorubicin—hematologic cancer	1.9e-05	0.000111	CcSEcCtD
Quinidine—Decreased appetite—Betamethasone—hematologic cancer	1.9e-05	0.000111	CcSEcCtD
Quinidine—Decreased appetite—Dexamethasone—hematologic cancer	1.9e-05	0.000111	CcSEcCtD
Quinidine—Nausea—Irinotecan—hematologic cancer	1.9e-05	0.000111	CcSEcCtD
Quinidine—Nausea—Mitoxantrone—hematologic cancer	1.9e-05	0.000111	CcSEcCtD
Quinidine—Immune system disorder—Epirubicin—hematologic cancer	1.89e-05	0.000111	CcSEcCtD
Quinidine—Mediastinal disorder—Epirubicin—hematologic cancer	1.89e-05	0.00011	CcSEcCtD
Quinidine—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.89e-05	0.00011	CcSEcCtD
Quinidine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.89e-05	0.00011	CcSEcCtD
Quinidine—Chills—Epirubicin—hematologic cancer	1.88e-05	0.00011	CcSEcCtD
Quinidine—Pruritus—Etoposide—hematologic cancer	1.88e-05	0.00011	CcSEcCtD
Quinidine—Shock—Prednisone—hematologic cancer	1.87e-05	0.00011	CcSEcCtD
Quinidine—Visual impairment—Doxorubicin—hematologic cancer	1.87e-05	0.000109	CcSEcCtD
Quinidine—Nervous system disorder—Prednisone—hematologic cancer	1.87e-05	0.000109	CcSEcCtD
Quinidine—Tachycardia—Prednisone—hematologic cancer	1.86e-05	0.000109	CcSEcCtD
Quinidine—Skin disorder—Prednisone—hematologic cancer	1.85e-05	0.000108	CcSEcCtD
Quinidine—Nausea—Gemcitabine—hematologic cancer	1.85e-05	0.000108	CcSEcCtD
Quinidine—Vomiting—Cisplatin—hematologic cancer	1.85e-05	0.000108	CcSEcCtD
Quinidine—Hyperhidrosis—Prednisone—hematologic cancer	1.84e-05	0.000108	CcSEcCtD
Quinidine—Vision blurred—Methotrexate—hematologic cancer	1.84e-05	0.000107	CcSEcCtD
Quinidine—Mental disorder—Epirubicin—hematologic cancer	1.84e-05	0.000107	CcSEcCtD
Quinidine—Erythema multiforme—Doxorubicin—hematologic cancer	1.84e-05	0.000107	CcSEcCtD
Quinidine—Rash—Cisplatin—hematologic cancer	1.83e-05	0.000107	CcSEcCtD
Quinidine—Dermatitis—Cisplatin—hematologic cancer	1.83e-05	0.000107	CcSEcCtD
Quinidine—Erythema—Epirubicin—hematologic cancer	1.83e-05	0.000107	CcSEcCtD
Quinidine—Malnutrition—Epirubicin—hematologic cancer	1.83e-05	0.000107	CcSEcCtD
Quinidine—Diarrhoea—Etoposide—hematologic cancer	1.82e-05	0.000106	CcSEcCtD
Quinidine—Anorexia—Prednisone—hematologic cancer	1.82e-05	0.000106	CcSEcCtD
Quinidine—Eye disorder—Doxorubicin—hematologic cancer	1.81e-05	0.000106	CcSEcCtD
Quinidine—Tinnitus—Doxorubicin—hematologic cancer	1.81e-05	0.000106	CcSEcCtD
Quinidine—Feeling abnormal—Betamethasone—hematologic cancer	1.8e-05	0.000105	CcSEcCtD
Quinidine—Feeling abnormal—Dexamethasone—hematologic cancer	1.8e-05	0.000105	CcSEcCtD
Quinidine—Cardiac disorder—Doxorubicin—hematologic cancer	1.8e-05	0.000105	CcSEcCtD
Quinidine—Flushing—Doxorubicin—hematologic cancer	1.8e-05	0.000105	CcSEcCtD
Quinidine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.79e-05	0.000105	CcSEcCtD
Quinidine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.79e-05	0.000105	CcSEcCtD
Quinidine—Hypersensitivity—Triamcinolone—hematologic cancer	1.78e-05	0.000104	CcSEcCtD
Quinidine—Dizziness—Etoposide—hematologic cancer	1.76e-05	0.000103	CcSEcCtD
Quinidine—Immune system disorder—Doxorubicin—hematologic cancer	1.75e-05	0.000102	CcSEcCtD
Quinidine—Vertigo—Methotrexate—hematologic cancer	1.75e-05	0.000102	CcSEcCtD
Quinidine—Mediastinal disorder—Doxorubicin—hematologic cancer	1.75e-05	0.000102	CcSEcCtD
Quinidine—Leukopenia—Methotrexate—hematologic cancer	1.75e-05	0.000102	CcSEcCtD
Quinidine—Chills—Doxorubicin—hematologic cancer	1.74e-05	0.000102	CcSEcCtD
Quinidine—Urticaria—Dexamethasone—hematologic cancer	1.74e-05	0.000102	CcSEcCtD
Quinidine—Urticaria—Betamethasone—hematologic cancer	1.74e-05	0.000102	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.74e-05	0.000101	CcSEcCtD
Quinidine—Dizziness—Prednisolone—hematologic cancer	1.73e-05	0.000101	CcSEcCtD
Quinidine—Asthenia—Triamcinolone—hematologic cancer	1.73e-05	0.000101	CcSEcCtD
Quinidine—Abdominal pain—Dexamethasone—hematologic cancer	1.73e-05	0.000101	CcSEcCtD
Quinidine—Abdominal pain—Betamethasone—hematologic cancer	1.73e-05	0.000101	CcSEcCtD
Quinidine—Body temperature increased—Dexamethasone—hematologic cancer	1.73e-05	0.000101	CcSEcCtD
Quinidine—Body temperature increased—Betamethasone—hematologic cancer	1.73e-05	0.000101	CcSEcCtD
Quinidine—Nausea—Cisplatin—hematologic cancer	1.72e-05	0.000101	CcSEcCtD
Quinidine—Vision blurred—Epirubicin—hematologic cancer	1.72e-05	0.000101	CcSEcCtD
Quinidine—Pruritus—Triamcinolone—hematologic cancer	1.71e-05	9.97e-05	CcSEcCtD
Quinidine—Mental disorder—Doxorubicin—hematologic cancer	1.7e-05	9.94e-05	CcSEcCtD
Quinidine—Convulsion—Methotrexate—hematologic cancer	1.69e-05	9.88e-05	CcSEcCtD
Quinidine—Vomiting—Etoposide—hematologic cancer	1.69e-05	9.88e-05	CcSEcCtD
Quinidine—Malnutrition—Doxorubicin—hematologic cancer	1.69e-05	9.87e-05	CcSEcCtD
Quinidine—Erythema—Doxorubicin—hematologic cancer	1.69e-05	9.87e-05	CcSEcCtD
Quinidine—Agitation—Epirubicin—hematologic cancer	1.68e-05	9.81e-05	CcSEcCtD
Quinidine—Rash—Etoposide—hematologic cancer	1.68e-05	9.8e-05	CcSEcCtD
Quinidine—Dermatitis—Etoposide—hematologic cancer	1.67e-05	9.79e-05	CcSEcCtD
Quinidine—Headache—Etoposide—hematologic cancer	1.67e-05	9.73e-05	CcSEcCtD
Quinidine—Myalgia—Methotrexate—hematologic cancer	1.66e-05	9.71e-05	CcSEcCtD
Quinidine—Chest pain—Methotrexate—hematologic cancer	1.66e-05	9.71e-05	CcSEcCtD
Quinidine—Decreased appetite—Prednisone—hematologic cancer	1.66e-05	9.68e-05	CcSEcCtD
Quinidine—Rash—Prednisolone—hematologic cancer	1.65e-05	9.66e-05	CcSEcCtD
Quinidine—Dermatitis—Prednisolone—hematologic cancer	1.65e-05	9.65e-05	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.65e-05	9.64e-05	CcSEcCtD
Quinidine—Headache—Prednisolone—hematologic cancer	1.64e-05	9.6e-05	CcSEcCtD
Quinidine—Vertigo—Epirubicin—hematologic cancer	1.64e-05	9.59e-05	CcSEcCtD
Quinidine—Syncope—Epirubicin—hematologic cancer	1.64e-05	9.57e-05	CcSEcCtD
Quinidine—Leukopenia—Epirubicin—hematologic cancer	1.63e-05	9.55e-05	CcSEcCtD
Quinidine—Palpitations—Epirubicin—hematologic cancer	1.61e-05	9.43e-05	CcSEcCtD
Quinidine—Confusional state—Methotrexate—hematologic cancer	1.61e-05	9.38e-05	CcSEcCtD
Quinidine—Loss of consciousness—Epirubicin—hematologic cancer	1.6e-05	9.38e-05	CcSEcCtD
Quinidine—Dizziness—Triamcinolone—hematologic cancer	1.59e-05	9.32e-05	CcSEcCtD
Quinidine—Vision blurred—Doxorubicin—hematologic cancer	1.59e-05	9.31e-05	CcSEcCtD
Quinidine—Convulsion—Epirubicin—hematologic cancer	1.58e-05	9.25e-05	CcSEcCtD
Quinidine—Nausea—Etoposide—hematologic cancer	1.58e-05	9.23e-05	CcSEcCtD
Quinidine—Feeling abnormal—Prednisone—hematologic cancer	1.57e-05	9.18e-05	CcSEcCtD
Quinidine—Asthenia—Betamethasone—hematologic cancer	1.57e-05	9.17e-05	CcSEcCtD
Quinidine—Asthenia—Dexamethasone—hematologic cancer	1.57e-05	9.17e-05	CcSEcCtD
Quinidine—Nervous system disorder—Methotrexate—hematologic cancer	1.56e-05	9.13e-05	CcSEcCtD
Quinidine—Thrombocytopenia—Methotrexate—hematologic cancer	1.56e-05	9.11e-05	CcSEcCtD
Quinidine—Gastrointestinal pain—Prednisone—hematologic cancer	1.56e-05	9.11e-05	CcSEcCtD
Quinidine—Nausea—Prednisolone—hematologic cancer	1.56e-05	9.1e-05	CcSEcCtD
Quinidine—Myalgia—Epirubicin—hematologic cancer	1.55e-05	9.08e-05	CcSEcCtD
Quinidine—Chest pain—Epirubicin—hematologic cancer	1.55e-05	9.08e-05	CcSEcCtD
Quinidine—Agitation—Doxorubicin—hematologic cancer	1.55e-05	9.07e-05	CcSEcCtD
Quinidine—Pruritus—Dexamethasone—hematologic cancer	1.55e-05	9.05e-05	CcSEcCtD
Quinidine—Pruritus—Betamethasone—hematologic cancer	1.55e-05	9.05e-05	CcSEcCtD
Quinidine—Skin disorder—Methotrexate—hematologic cancer	1.55e-05	9.04e-05	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.54e-05	9.02e-05	CcSEcCtD
Quinidine—Hyperhidrosis—Methotrexate—hematologic cancer	1.54e-05	9e-05	CcSEcCtD
Quinidine—Vomiting—Triamcinolone—hematologic cancer	1.53e-05	8.96e-05	CcSEcCtD
Quinidine—Rash—Triamcinolone—hematologic cancer	1.52e-05	8.89e-05	CcSEcCtD
Quinidine—Dermatitis—Triamcinolone—hematologic cancer	1.52e-05	8.88e-05	CcSEcCtD
Quinidine—Vertigo—Doxorubicin—hematologic cancer	1.52e-05	8.87e-05	CcSEcCtD
Quinidine—Anorexia—Methotrexate—hematologic cancer	1.52e-05	8.87e-05	CcSEcCtD
Quinidine—Syncope—Doxorubicin—hematologic cancer	1.52e-05	8.85e-05	CcSEcCtD
Quinidine—Urticaria—Prednisone—hematologic cancer	1.51e-05	8.85e-05	CcSEcCtD
Quinidine—Leukopenia—Doxorubicin—hematologic cancer	1.51e-05	8.84e-05	CcSEcCtD
Quinidine—Headache—Triamcinolone—hematologic cancer	1.51e-05	8.83e-05	CcSEcCtD
Quinidine—Abdominal pain—Prednisone—hematologic cancer	1.51e-05	8.8e-05	CcSEcCtD
Quinidine—Body temperature increased—Prednisone—hematologic cancer	1.51e-05	8.8e-05	CcSEcCtD
Quinidine—Confusional state—Epirubicin—hematologic cancer	1.5e-05	8.78e-05	CcSEcCtD
Quinidine—Diarrhoea—Dexamethasone—hematologic cancer	1.5e-05	8.75e-05	CcSEcCtD
Quinidine—Diarrhoea—Betamethasone—hematologic cancer	1.5e-05	8.75e-05	CcSEcCtD
Quinidine—Palpitations—Doxorubicin—hematologic cancer	1.49e-05	8.73e-05	CcSEcCtD
Quinidine—Oedema—Epirubicin—hematologic cancer	1.49e-05	8.71e-05	CcSEcCtD
Quinidine—Hypotension—Methotrexate—hematologic cancer	1.49e-05	8.7e-05	CcSEcCtD
Quinidine—Loss of consciousness—Doxorubicin—hematologic cancer	1.49e-05	8.68e-05	CcSEcCtD
Quinidine—Shock—Epirubicin—hematologic cancer	1.47e-05	8.57e-05	CcSEcCtD
Quinidine—Convulsion—Doxorubicin—hematologic cancer	1.46e-05	8.55e-05	CcSEcCtD
Quinidine—Nervous system disorder—Epirubicin—hematologic cancer	1.46e-05	8.54e-05	CcSEcCtD
Quinidine—Thrombocytopenia—Epirubicin—hematologic cancer	1.46e-05	8.53e-05	CcSEcCtD
Quinidine—Tachycardia—Epirubicin—hematologic cancer	1.45e-05	8.5e-05	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.45e-05	8.48e-05	CcSEcCtD
Quinidine—Skin disorder—Epirubicin—hematologic cancer	1.45e-05	8.46e-05	CcSEcCtD
Quinidine—Dizziness—Dexamethasone—hematologic cancer	1.45e-05	8.46e-05	CcSEcCtD
Quinidine—Dizziness—Betamethasone—hematologic cancer	1.45e-05	8.46e-05	CcSEcCtD
Quinidine—Hyperhidrosis—Epirubicin—hematologic cancer	1.44e-05	8.42e-05	CcSEcCtD
Quinidine—Chest pain—Doxorubicin—hematologic cancer	1.44e-05	8.41e-05	CcSEcCtD
Quinidine—Myalgia—Doxorubicin—hematologic cancer	1.44e-05	8.41e-05	CcSEcCtD
Quinidine—Nausea—Triamcinolone—hematologic cancer	1.43e-05	8.37e-05	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.43e-05	8.35e-05	CcSEcCtD
Quinidine—Anorexia—Epirubicin—hematologic cancer	1.42e-05	8.3e-05	CcSEcCtD
Quinidine—Dyspnoea—Methotrexate—hematologic cancer	1.42e-05	8.3e-05	CcSEcCtD
Quinidine—Hypersensitivity—Prednisone—hematologic cancer	1.4e-05	8.2e-05	CcSEcCtD
Quinidine—Hypotension—Epirubicin—hematologic cancer	1.39e-05	8.14e-05	CcSEcCtD
Quinidine—Vomiting—Betamethasone—hematologic cancer	1.39e-05	8.13e-05	CcSEcCtD
Quinidine—Vomiting—Dexamethasone—hematologic cancer	1.39e-05	8.13e-05	CcSEcCtD
Quinidine—Confusional state—Doxorubicin—hematologic cancer	1.39e-05	8.13e-05	CcSEcCtD
Quinidine—Decreased appetite—Methotrexate—hematologic cancer	1.38e-05	8.09e-05	CcSEcCtD
Quinidine—Rash—Dexamethasone—hematologic cancer	1.38e-05	8.06e-05	CcSEcCtD
Quinidine—Rash—Betamethasone—hematologic cancer	1.38e-05	8.06e-05	CcSEcCtD
Quinidine—Oedema—Doxorubicin—hematologic cancer	1.38e-05	8.06e-05	CcSEcCtD
Quinidine—Dermatitis—Dexamethasone—hematologic cancer	1.38e-05	8.05e-05	CcSEcCtD
Quinidine—Dermatitis—Betamethasone—hematologic cancer	1.38e-05	8.05e-05	CcSEcCtD
Quinidine—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.37e-05	8.03e-05	CcSEcCtD
Quinidine—Headache—Betamethasone—hematologic cancer	1.37e-05	8.01e-05	CcSEcCtD
Quinidine—Headache—Dexamethasone—hematologic cancer	1.37e-05	8.01e-05	CcSEcCtD
Quinidine—Asthenia—Prednisone—hematologic cancer	1.37e-05	7.99e-05	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.36e-05	7.93e-05	CcSEcCtD
Quinidine—Shock—Doxorubicin—hematologic cancer	1.36e-05	7.93e-05	CcSEcCtD
Quinidine—Nervous system disorder—Doxorubicin—hematologic cancer	1.35e-05	7.9e-05	CcSEcCtD
Quinidine—Thrombocytopenia—Doxorubicin—hematologic cancer	1.35e-05	7.89e-05	CcSEcCtD
Quinidine—Pruritus—Prednisone—hematologic cancer	1.35e-05	7.88e-05	CcSEcCtD
Quinidine—Tachycardia—Doxorubicin—hematologic cancer	1.35e-05	7.86e-05	CcSEcCtD
Quinidine—Skin disorder—Doxorubicin—hematologic cancer	1.34e-05	7.83e-05	CcSEcCtD
Quinidine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.33e-05	7.79e-05	CcSEcCtD
Quinidine—Dyspnoea—Epirubicin—hematologic cancer	1.33e-05	7.76e-05	CcSEcCtD
Quinidine—Anorexia—Doxorubicin—hematologic cancer	1.31e-05	7.68e-05	CcSEcCtD
Quinidine—Feeling abnormal—Methotrexate—hematologic cancer	1.31e-05	7.67e-05	CcSEcCtD
Quinidine—Diarrhoea—Prednisone—hematologic cancer	1.3e-05	7.62e-05	CcSEcCtD
Quinidine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.3e-05	7.61e-05	CcSEcCtD
Quinidine—Nausea—Dexamethasone—hematologic cancer	1.3e-05	7.6e-05	CcSEcCtD
Quinidine—Nausea—Betamethasone—hematologic cancer	1.3e-05	7.6e-05	CcSEcCtD
Quinidine—Decreased appetite—Epirubicin—hematologic cancer	1.3e-05	7.57e-05	CcSEcCtD
Quinidine—Hypotension—Doxorubicin—hematologic cancer	1.29e-05	7.53e-05	CcSEcCtD
Quinidine—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.29e-05	7.52e-05	CcSEcCtD
Quinidine—Urticaria—Methotrexate—hematologic cancer	1.27e-05	7.39e-05	CcSEcCtD
Quinidine—Dizziness—Prednisone—hematologic cancer	1.26e-05	7.36e-05	CcSEcCtD
Quinidine—Abdominal pain—Methotrexate—hematologic cancer	1.26e-05	7.36e-05	CcSEcCtD
Quinidine—Body temperature increased—Methotrexate—hematologic cancer	1.26e-05	7.36e-05	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.26e-05	7.34e-05	CcSEcCtD
Quinidine—Dyspnoea—Doxorubicin—hematologic cancer	1.23e-05	7.18e-05	CcSEcCtD
Quinidine—Feeling abnormal—Epirubicin—hematologic cancer	1.23e-05	7.18e-05	CcSEcCtD
Quinidine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.22e-05	7.12e-05	CcSEcCtD
Quinidine—Vomiting—Prednisone—hematologic cancer	1.21e-05	7.08e-05	CcSEcCtD
Quinidine—Rash—Prednisone—hematologic cancer	1.2e-05	7.02e-05	CcSEcCtD
Quinidine—Dermatitis—Prednisone—hematologic cancer	1.2e-05	7.01e-05	CcSEcCtD
Quinidine—Decreased appetite—Doxorubicin—hematologic cancer	1.2e-05	7.01e-05	CcSEcCtD
Quinidine—Headache—Prednisone—hematologic cancer	1.19e-05	6.98e-05	CcSEcCtD
Quinidine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.19e-05	6.96e-05	CcSEcCtD
Quinidine—Urticaria—Epirubicin—hematologic cancer	1.18e-05	6.92e-05	CcSEcCtD
Quinidine—Abdominal pain—Epirubicin—hematologic cancer	1.18e-05	6.88e-05	CcSEcCtD
Quinidine—Body temperature increased—Epirubicin—hematologic cancer	1.18e-05	6.88e-05	CcSEcCtD
Quinidine—Hypersensitivity—Methotrexate—hematologic cancer	1.17e-05	6.86e-05	CcSEcCtD
Quinidine—Asthenia—Methotrexate—hematologic cancer	1.14e-05	6.68e-05	CcSEcCtD
Quinidine—Feeling abnormal—Doxorubicin—hematologic cancer	1.14e-05	6.64e-05	CcSEcCtD
Quinidine—Nausea—Prednisone—hematologic cancer	1.13e-05	6.61e-05	CcSEcCtD
Quinidine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.13e-05	6.59e-05	CcSEcCtD
Quinidine—Pruritus—Methotrexate—hematologic cancer	1.13e-05	6.58e-05	CcSEcCtD
Quinidine—Hypersensitivity—Epirubicin—hematologic cancer	1.1e-05	6.42e-05	CcSEcCtD
Quinidine—Urticaria—Doxorubicin—hematologic cancer	1.1e-05	6.4e-05	CcSEcCtD
Quinidine—Abdominal pain—Doxorubicin—hematologic cancer	1.09e-05	6.37e-05	CcSEcCtD
Quinidine—Body temperature increased—Doxorubicin—hematologic cancer	1.09e-05	6.37e-05	CcSEcCtD
Quinidine—Diarrhoea—Methotrexate—hematologic cancer	1.09e-05	6.37e-05	CcSEcCtD
Quinidine—Asthenia—Epirubicin—hematologic cancer	1.07e-05	6.25e-05	CcSEcCtD
Quinidine—Pruritus—Epirubicin—hematologic cancer	1.05e-05	6.16e-05	CcSEcCtD
Quinidine—Dizziness—Methotrexate—hematologic cancer	1.05e-05	6.15e-05	CcSEcCtD
Quinidine—Diarrhoea—Epirubicin—hematologic cancer	1.02e-05	5.96e-05	CcSEcCtD
Quinidine—Hypersensitivity—Doxorubicin—hematologic cancer	1.02e-05	5.94e-05	CcSEcCtD
Quinidine—Vomiting—Methotrexate—hematologic cancer	1.01e-05	5.92e-05	CcSEcCtD
Quinidine—Rash—Methotrexate—hematologic cancer	1e-05	5.87e-05	CcSEcCtD
Quinidine—Dermatitis—Methotrexate—hematologic cancer	1e-05	5.86e-05	CcSEcCtD
Quinidine—Headache—Methotrexate—hematologic cancer	9.98e-06	5.83e-05	CcSEcCtD
Quinidine—Asthenia—Doxorubicin—hematologic cancer	9.89e-06	5.78e-05	CcSEcCtD
Quinidine—Dizziness—Epirubicin—hematologic cancer	9.86e-06	5.76e-05	CcSEcCtD
Quinidine—Pruritus—Doxorubicin—hematologic cancer	9.76e-06	5.7e-05	CcSEcCtD
Quinidine—Vomiting—Epirubicin—hematologic cancer	9.48e-06	5.54e-05	CcSEcCtD
Quinidine—Nausea—Methotrexate—hematologic cancer	9.46e-06	5.53e-05	CcSEcCtD
Quinidine—Diarrhoea—Doxorubicin—hematologic cancer	9.43e-06	5.51e-05	CcSEcCtD
Quinidine—Rash—Epirubicin—hematologic cancer	9.4e-06	5.49e-05	CcSEcCtD
Quinidine—Dermatitis—Epirubicin—hematologic cancer	9.39e-06	5.49e-05	CcSEcCtD
Quinidine—Headache—Epirubicin—hematologic cancer	9.34e-06	5.46e-05	CcSEcCtD
Quinidine—Dizziness—Doxorubicin—hematologic cancer	9.12e-06	5.33e-05	CcSEcCtD
Quinidine—Nausea—Epirubicin—hematologic cancer	8.85e-06	5.17e-05	CcSEcCtD
Quinidine—Vomiting—Doxorubicin—hematologic cancer	8.77e-06	5.12e-05	CcSEcCtD
Quinidine—Rash—Doxorubicin—hematologic cancer	8.69e-06	5.08e-05	CcSEcCtD
Quinidine—Dermatitis—Doxorubicin—hematologic cancer	8.69e-06	5.08e-05	CcSEcCtD
Quinidine—Headache—Doxorubicin—hematologic cancer	8.64e-06	5.05e-05	CcSEcCtD
Quinidine—Nausea—Doxorubicin—hematologic cancer	8.19e-06	4.79e-05	CcSEcCtD
Quinidine—CYP3A7—Metabolism—ALB—hematologic cancer	1.83e-06	2.67e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—ALB—hematologic cancer	1.83e-06	2.67e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CREBBP—hematologic cancer	1.82e-06	2.66e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—MTHFR—hematologic cancer	1.82e-06	2.66e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.82e-06	2.66e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.82e-06	2.65e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CYCS—hematologic cancer	1.81e-06	2.63e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	1.81e-06	2.63e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	1.8e-06	2.62e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.79e-06	2.62e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL2—hematologic cancer	1.79e-06	2.61e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CYCS—hematologic cancer	1.79e-06	2.61e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TERT—hematologic cancer	1.79e-06	2.6e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PTEN—hematologic cancer	1.78e-06	2.6e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.78e-06	2.6e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.78e-06	2.6e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.78e-06	2.59e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.77e-06	2.58e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.77e-06	2.58e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	1.77e-06	2.57e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3R1—hematologic cancer	1.76e-06	2.56e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3R1—hematologic cancer	1.75e-06	2.55e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	1.74e-06	2.54e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CD—hematologic cancer	1.73e-06	2.52e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.73e-06	2.52e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—MTHFR—hematologic cancer	1.72e-06	2.51e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.72e-06	2.5e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—ALB—hematologic cancer	1.71e-06	2.49e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TSC2—hematologic cancer	1.7e-06	2.48e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—EP300—hematologic cancer	1.7e-06	2.48e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSTP1—hematologic cancer	1.69e-06	2.46e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NUP98—hematologic cancer	1.67e-06	2.44e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	1.64e-06	2.39e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3R1—hematologic cancer	1.63e-06	2.38e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.62e-06	2.37e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.62e-06	2.37e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	1.62e-06	2.37e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CB—hematologic cancer	1.62e-06	2.36e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NQO1—hematologic cancer	1.62e-06	2.36e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CD44—hematologic cancer	1.62e-06	2.36e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CB—hematologic cancer	1.62e-06	2.36e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NUP214—hematologic cancer	1.61e-06	2.35e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.6e-06	2.34e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTP1—hematologic cancer	1.59e-06	2.32e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ESR1—hematologic cancer	1.59e-06	2.32e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.58e-06	2.31e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—MTR—hematologic cancer	1.58e-06	2.3e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.58e-06	2.3e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.58e-06	2.3e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.58e-06	2.3e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—FN1—hematologic cancer	1.57e-06	2.29e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	1.56e-06	2.28e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	1.55e-06	2.27e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—BAD—hematologic cancer	1.55e-06	2.27e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—NCOR1—hematologic cancer	1.55e-06	2.26e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—GSTM1—hematologic cancer	1.55e-06	2.26e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ENO2—hematologic cancer	1.55e-06	2.26e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	1.54e-06	2.24e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	1.53e-06	2.23e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CYCS—hematologic cancer	1.53e-06	2.23e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.53e-06	2.23e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTEN—hematologic cancer	1.53e-06	2.22e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.52e-06	2.22e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.51e-06	2.21e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CD80—hematologic cancer	1.51e-06	2.2e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CB—hematologic cancer	1.51e-06	2.2e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ABCB1—hematologic cancer	1.51e-06	2.2e-05	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PIK3CA—hematologic cancer	1.51e-06	2.2e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KIT—hematologic cancer	1.5e-06	2.19e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	1.5e-06	2.19e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	1.5e-06	2.19e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.5e-06	2.19e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ABCB1—hematologic cancer	1.49e-06	2.18e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	1.48e-06	2.16e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SDC1—hematologic cancer	1.47e-06	2.14e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—NCOR1—hematologic cancer	1.46e-06	2.13e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—GSTM1—hematologic cancer	1.46e-06	2.13e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—EP300—hematologic cancer	1.45e-06	2.12e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.45e-06	2.12e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.45e-06	2.12e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CREBBP—hematologic cancer	1.45e-06	2.11e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CG—hematologic cancer	1.44e-06	2.1e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	1.44e-06	2.1e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CREB1—hematologic cancer	1.43e-06	2.09e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CREBBP—hematologic cancer	1.42e-06	2.07e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—BRAF—hematologic cancer	1.41e-06	2.06e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCL2—hematologic cancer	1.4e-06	2.04e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTEN—hematologic cancer	1.4e-06	2.04e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTEN—hematologic cancer	1.4e-06	2.04e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL6R—hematologic cancer	1.4e-06	2.04e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	1.4e-06	2.03e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.39e-06	2.02e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	1.37e-06	2e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—MTHFR—hematologic cancer	1.37e-06	2e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.37e-06	2e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—ALB—hematologic cancer	1.36e-06	1.98e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.35e-06	1.97e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	1.35e-06	1.96e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CREBBP—hematologic cancer	1.34e-06	1.95e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—EP300—hematologic cancer	1.34e-06	1.95e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—EP300—hematologic cancer	1.33e-06	1.94e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	1.33e-06	1.94e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—ALB—hematologic cancer	1.33e-06	1.94e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.32e-06	1.93e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	1.32e-06	1.93e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.31e-06	1.91e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.31e-06	1.9e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTEN—hematologic cancer	1.3e-06	1.9e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	1.3e-06	1.89e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	1.3e-06	1.89e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.29e-06	1.89e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.28e-06	1.87e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.28e-06	1.86e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	1.27e-06	1.85e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CD—hematologic cancer	1.27e-06	1.85e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—FGF2—hematologic cancer	1.27e-06	1.85e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	1.26e-06	1.83e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—ALB—hematologic cancer	1.25e-06	1.83e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	1.25e-06	1.82e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CD44—hematologic cancer	1.25e-06	1.82e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NQO1—hematologic cancer	1.25e-06	1.82e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—EP300—hematologic cancer	1.24e-06	1.81e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.24e-06	1.81e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.24e-06	1.81e-05	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—AKT1—hematologic cancer	1.23e-06	1.8e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.23e-06	1.79e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—JAK2—hematologic cancer	1.21e-06	1.77e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3R1—hematologic cancer	1.2e-06	1.75e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	1.2e-06	1.75e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	1.19e-06	1.73e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MDM2—hematologic cancer	1.19e-06	1.73e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CYCS—hematologic cancer	1.18e-06	1.72e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.17e-06	1.71e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	1.17e-06	1.71e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.16e-06	1.7e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.15e-06	1.68e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MTOR—hematologic cancer	1.15e-06	1.68e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	1.15e-06	1.68e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—ALB—hematologic cancer	1.15e-06	1.67e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.13e-06	1.65e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CB—hematologic cancer	1.11e-06	1.61e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	1.1e-06	1.61e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.1e-06	1.6e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.1e-06	1.6e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.09e-06	1.58e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	1.08e-06	1.58e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.08e-06	1.57e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	1.08e-06	1.57e-05	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	1.07e-06	1.56e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.07e-06	1.56e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	1.06e-06	1.55e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL2—hematologic cancer	1.06e-06	1.54e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	1.05e-06	1.54e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.04e-06	1.52e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTEN—hematologic cancer	1.04e-06	1.51e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	1.03e-06	1.51e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—JUN—hematologic cancer	1.03e-06	1.5e-05	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—AKT1—hematologic cancer	1.03e-06	1.5e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.01e-06	1.48e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTEN—hematologic cancer	1.01e-06	1.48e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.01e-06	1.48e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.01e-06	1.47e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—ALB—hematologic cancer	1e-06	1.46e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CREBBP—hematologic cancer	9.99e-07	1.46e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	9.99e-07	1.46e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	9.96e-07	1.45e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PIK3CA—hematologic cancer	9.88e-07	1.44e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—EP300—hematologic cancer	9.87e-07	1.44e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PIK3CA—hematologic cancer	9.86e-07	1.44e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ABCB1—hematologic cancer	9.86e-07	1.44e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	9.75e-07	1.42e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	9.72e-07	1.42e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—EP300—hematologic cancer	9.67e-07	1.41e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.66e-07	1.41e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3R1—hematologic cancer	9.57e-07	1.4e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NCOR1—hematologic cancer	9.57e-07	1.39e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—GSTM1—hematologic cancer	9.57e-07	1.39e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTEN—hematologic cancer	9.56e-07	1.39e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	9.55e-07	1.39e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EP300—hematologic cancer	9.5e-07	1.39e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	9.47e-07	1.38e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—ALB—hematologic cancer	9.43e-07	1.37e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—ALB—hematologic cancer	9.35e-07	1.36e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SRC—hematologic cancer	9.24e-07	1.35e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	9.21e-07	1.34e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	9.19e-07	1.34e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—EP300—hematologic cancer	9.12e-07	1.33e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	9.02e-07	1.32e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	9e-07	1.31e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	8.94e-07	1.3e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	8.91e-07	1.3e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	8.89e-07	1.3e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CB—hematologic cancer	8.84e-07	1.29e-05	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—AKT1—hematologic cancer	8.79e-07	1.28e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTEN—hematologic cancer	8.76e-07	1.28e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CREBBP—hematologic cancer	8.54e-07	1.24e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	8.51e-07	1.24e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—MTHFR—hematologic cancer	8.46e-07	1.23e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—EP300—hematologic cancer	8.36e-07	1.22e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	8.33e-07	1.21e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MYC—hematologic cancer	8.28e-07	1.21e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	8.26e-07	1.2e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	8.25e-07	1.2e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	8.09e-07	1.18e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—AKT1—hematologic cancer	8.07e-07	1.18e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—AKT1—hematologic cancer	8.06e-07	1.17e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—ALB—hematologic cancer	7.99e-07	1.16e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	7.65e-07	1.12e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	7.64e-07	1.11e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTEN—hematologic cancer	7.64e-07	1.11e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—AKT1—hematologic cancer	7.51e-07	1.09e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	7.3e-07	1.06e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—EP300—hematologic cancer	7.28e-07	1.06e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTEN—hematologic cancer	7.2e-07	1.05e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	7.15e-07	1.04e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTEN—hematologic cancer	7.13e-07	1.04e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	7.1e-07	1.04e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	7.05e-07	1.03e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	7.03e-07	1.02e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—EP300—hematologic cancer	6.86e-07	1e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—EP300—hematologic cancer	6.8e-07	9.92e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TP53—hematologic cancer	6.8e-07	9.91e-06	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PIK3CA—hematologic cancer	6.74e-07	9.83e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CREBBP—hematologic cancer	6.59e-07	9.6e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	6.5e-07	9.48e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	6.25e-07	9.11e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—IL6—hematologic cancer	6.22e-07	9.07e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	6.18e-07	9.01e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—ALB—hematologic cancer	6.17e-07	8.99e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTEN—hematologic cancer	6.1e-07	8.89e-06	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—AKT1—hematologic cancer	5.97e-07	8.7e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	5.9e-07	8.6e-06	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—AKT1—hematologic cancer	5.84e-07	8.52e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—EP300—hematologic cancer	5.81e-07	8.47e-06	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	5.74e-07	8.37e-06	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—AKT1—hematologic cancer	5.51e-07	8.03e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	5.44e-07	7.94e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PIK3CA—hematologic cancer	5.39e-07	7.85e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	5.08e-07	7.4e-06	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—AKT1—hematologic cancer	5.05e-07	7.36e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	5.03e-07	7.34e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTEN—hematologic cancer	4.7e-07	6.86e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—EP300—hematologic cancer	4.49e-07	6.54e-06	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—AKT1—hematologic cancer	4.4e-07	6.42e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	4.3e-07	6.27e-06	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—AKT1—hematologic cancer	4.15e-07	6.05e-06	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—AKT1—hematologic cancer	4.11e-07	5.99e-06	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—AKT1—hematologic cancer	3.51e-07	5.12e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	3.32e-07	4.84e-06	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—AKT1—hematologic cancer	2.71e-07	3.95e-06	CbGpPWpGaD
